177 related articles for article (PubMed ID: 16607158)
1. Neurological symptoms suggestive of demyelination in Crohn's disease after infliximab therapy.
Dubcenco E; Ottaway CA; Chen DL; Baker JP
Eur J Gastroenterol Hepatol; 2006 May; 18(5):565-6. PubMed ID: 16607158
[TBL] [Abstract][Full Text] [Related]
2. Demyelination during anti-tumor necrosis factor alpha therapy with infliximab for Crohn's disease.
Thomas CW; Weinshenker BG; Sandborn WJ
Inflamm Bowel Dis; 2004 Jan; 10(1):28-31. PubMed ID: 15058523
[TBL] [Abstract][Full Text] [Related]
3. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
Magro F; Portela F
BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
[TBL] [Abstract][Full Text] [Related]
4. Anti-TNF therapy for Crohn's disease: a perspective (infliximab is not the drug we have been waiting for).
Shanahan F
Inflamm Bowel Dis; 2000 May; 6(2):137-9. PubMed ID: 10833074
[No Abstract] [Full Text] [Related]
5. Severe pneumococcal pneumonia following treatment with infliximab for Crohn's disease.
Ritz MA; Jost R
Inflamm Bowel Dis; 2001 Nov; 7(4):327. PubMed ID: 11720324
[No Abstract] [Full Text] [Related]
6. Infliximab-induced thrombocytopenia in an elderly patient with ileocolonic Crohn's disease.
Mocciaro F; Russo G; Di Mitri R; Marino A
Inflamm Bowel Dis; 2013; 19(4):E52-3. PubMed ID: 22535599
[No Abstract] [Full Text] [Related]
7. Severe Listeria meningoencephalitis in an infliximab-treated patient with Crohn's disease.
Izbéki F; Nagy F; Szepes Z; Kiss I; Lonovics J; Molnár T
Inflamm Bowel Dis; 2008 Mar; 14(3):429-31. PubMed ID: 17973302
[No Abstract] [Full Text] [Related]
8. Pericarditis as a complication of infliximab therapy in Crohn's disease.
Burke JP; Kelleher B; Ramadan S; Quinlan M; Sugrue D; O'Donovan MA
Inflamm Bowel Dis; 2008 Mar; 14(3):428-9. PubMed ID: 17924565
[No Abstract] [Full Text] [Related]
9. Demyelination-like syndrome in Crohn's disease after infliximab therapy.
Freeman HJ; Flak B
Can J Gastroenterol; 2005 May; 19(5):313-6. PubMed ID: 15915246
[TBL] [Abstract][Full Text] [Related]
10. Preventing TB in patients with Crohn's disease needing infliximab or other anti-TNF therapy.
Rampton DS
Gut; 2005 Oct; 54(10):1360-2. PubMed ID: 16113045
[No Abstract] [Full Text] [Related]
11. Another paradox in Crohn's disease: new onset of psoriasis in a patient receiving tumor necrosis factor-alpha antagonist.
Angelucci E; Cocco A; Viscido A; Vernia P; Caprilli R
Inflamm Bowel Dis; 2007 Aug; 13(8):1059-61. PubMed ID: 17387676
[No Abstract] [Full Text] [Related]
12. Monoclonal antibody therapy for Crohn's disease.
Selby W
Intern Med J; 2001 Mar; 31(2):73-4. PubMed ID: 11480481
[No Abstract] [Full Text] [Related]
13. Severe agranulocytosis following first infliximab infusion in Crohn's disease.
Rosales-Zábal JM; Fernández-Pérez F; Albandea-Moreno C; Vera-Rivero FM; Navarro-Jarabo JM
Inflamm Bowel Dis; 2011 Nov; 17(11):E147-8. PubMed ID: 21830280
[No Abstract] [Full Text] [Related]
14. Exacerbation of Mycobacterium tuberculosis enteritis masquerading as Crohn's disease after treatment with a tumor necrosis factor-alpha inhibitor.
Wagner TE; Huseby ES; Huseby JS
Am J Med; 2002 Jan; 112(1):67-9. PubMed ID: 11812409
[No Abstract] [Full Text] [Related]
15. Adalimumab-induced lupus erythematosus in Crohn's disease patients previously treated with infliximab.
Mañosa M; Domènech E; Marín L; Olivé A; Zabana Y; Cabré E; Gassull MA
Gut; 2008 Apr; 57(4):559; author reply 559-60. PubMed ID: 18334664
[No Abstract] [Full Text] [Related]
16. Hidradenitis suppurativa and Crohn's disease: response to treatment with infliximab.
Martínez F; Nos P; Benlloch S; Ponce J
Inflamm Bowel Dis; 2001 Nov; 7(4):323-6. PubMed ID: 11720323
[TBL] [Abstract][Full Text] [Related]
17. [Anti-TNF (infliximab) treatment in Crohn disease: safety profile].
Carroccio A; Di Prima L; Pirrone G; Ambrosiano G; Noto D; Cefalù AB
Recenti Prog Med; 2006 Feb; 97(2):108-12; quiz 122. PubMed ID: 16671277
[TBL] [Abstract][Full Text] [Related]
18. Acute paraplegia after the initiation of anti-tumour necrosis factor-alpha therapy for Crohn's disease.
Vadikolias K; Kouklakis G; Heliopoulos I; Argyropoulou P; Papanas N; Tzilonidou M; Prassopoulos P; Piperidou H
Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):159-62. PubMed ID: 17273002
[TBL] [Abstract][Full Text] [Related]
19. Crohn's disease, infliximab and idiopathic thrombocytopenic purpura.
Selby LA; Hess D; Shashidar H; de Villiers WJ; Selby LA
Inflamm Bowel Dis; 2004 Sep; 10(5):698-700. PubMed ID: 15472539
[No Abstract] [Full Text] [Related]
20. Genital condylomata in a patient receiving infliximab for Crohn's disease.
Somasekar A; Alcolado R
Postgrad Med J; 2004 Jun; 80(944):358-9. PubMed ID: 15192172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
